Clinical Trials

1 2 3 199
Number of results: 3972

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-08-18 birinapant and pembrozilumab treatment-resistant solid tumours 1-2 Medivir (Sweden) Cancer - Oncology
2017-08-17 KITE-718 (MAGE A3/A6 -Autologous genetically modified MAGE-A3/A6 TCR transduced T cells) solid tumors 1 Kite Pharma (USA - CA) Cancer - Oncology
2017-08-16 MIV-711 osteoarthritis 2 Medivir (Sweden) Rheumatic diseases - Inflammatory diseases – Bone diseases
2017-08-16 LN-145 cervical cancer 2 Lion Biotechnologies (USA - CA), now Iovance Biotherapeutics (USA - CA) Cancer - Oncology
2017-08-11 fimaChem technology inoperable extrahepatic bile duct cancer 1 PCI Biotech (Norway) Cancer - Oncology
2017-08-09 PRS-343 HER2-positive solid tumors preclinical Pieris (Germany) Cancer - Oncology
2017-08-08 KITE-585 relapsed/refractory multiple myeloma 1 Kite Pharma (USA - CA) Cancer - Oncology
2017-08-07 axicabtagene ciloleucel (KTE-C19) (autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3 zeta chimeric antigen receptor) refractory diffuse large B cell lymphoma, refractory primary mediastinal B cell lymphoma, refractory transformed follicular lymphoma 1-2 Kite Pharma (USA - CA) Cancer - Oncology - Rare diseases
2017-08-04 lasmiditan migraine 3 Eli Lilly (USA - IN) CNS diseases - Neurological diseases
2017-08-03 refractory aggressive non-Hodgkin lymphoma (NHL) Cancer - Oncology
2017-08-02 major depressive disorder, bipolar depression 23andMe (USA - CA) Lundbeck (Denmark) Milken Institute (USA - CA) CNS diseases - Mental diseases
2017-08-02 omecamtiv mecarbil heart failure 2 Cytokinetics (USA - CA) Cardiovascular diseases
2017-08-02 pracinostat acute myeloid leukemia (AML) 3 Mei Pharma (USA - CA) Helsinn Group (Switzerland) Cancer - Oncology
2017-08-02 axicabtagene ciloleucel (KTE-C19) (autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3 zeta chimeric antigen receptor) relapsed/refractory indolent B-cell non-Hodgkin lymphoma 2 Kite Pharma (USA - CA) Cancer - Oncology
2017-08-02 Pixuvri® (pixantrone) relapsed or refractory diffuse large B-cell lymphoma (DLBCL), or follicular grade 3 lymphoma 3 CTI BioPharma - previously known as Cell Therapeutics (USA - WA) Cancer - Oncology
2017-08-02 Viaskin® Peanut peanut allergy 3 DBV Technologies (France) Allergic diseases - Immunological diseases
2017-07-31 Pexa-Vec (pexastimogene devacirepvec) with Opdivo®(nivolumab) advanced hepatocellular carcinoma 1-2 Transgene (France) Cancer - Oncology
2017-07-27 BI 695501 (biosimilar version of adalimumab Humira®) psoriasis 3 Boehringer Ingelheim (Germany) Autoimmune diseases - Dermatological diseases
2017-07-27 durvalumab (MEDI4736) and tremelimumab non-small cell lung cancer (NSCLC) 3 AstraZeneca (UK) Cancer - Oncology
2017-07-25 rigosertib pediatric RASopathies (juvenile myelomonocytic leukemia, Onconova Therapeutics (USA - PA) Rare diseases - Genetic diseases